Unaudited Financial Results along with Limited Review Report for the quarter ended June 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
By the next day the stock moved 4.7 pts less than Nifty Microcap 250 and 4.7 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Roselabs Finance Ltd reported a loss of Rs 4.68 lakh for Q1FY26, marginally wider than the Rs 4.40 lakh loss in the same quarter last year. Revenue from operations stood at Rs 70.91 lakh, entirely matched by 'Cost of Projects' of Rs 70.20 lakh, indicating pass-through project revenue rather than profitable activity. Total expenses were just Rs 4.68 lakh, and the auditor MSKA & Associates issued an unmodified (clean) limited review opinion. The company's other equity remains deeply negative at Rs (1,472.76) lakh, reflecting accumulated losses against a paid-up capital of Rs 1,000 lakh. Importantly, the Board had approved a Scheme of Merger by Absorption with Lodha Developers Limited (formerly Macrotech Developers) in July 2024, subject to approvals.
Quarterly results are routine and immaterial for shareholders. The key pending event is the proposed merger with Lodha Developers, which could materially affect share valuation and is subject to regulatory and shareholder approvals. The deeply negative net worth is a structural concern, though the pending merger with the Lodha group may resolve it.